Literature DB >> 34159393

Inhibition of Transforming Growth Factor Beta and Immune Checkpoints Induces a Distinctively Distributed, Severe Bullous Pemphigoid.

Soo Hyun Choi1, Kyung Bae Chung2, Do-Young Kim2.   

Abstract

Entities:  

Keywords:  cancer immunotherapy; programmed cell death-1; transforming growth factor; bullous pemphigoid

Mesh：

Substances：

Year:  2021        PMID： 34159393      PMCID： PMC9380275          DOI： 10.2340/00015555-3853

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  9 in total

1.  Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.

Authors:  Emily Coleman; Christine Ko; Feng Dai; Mary M Tomayko; Harriet Kluger; Jonathan S Leventhal
Journal:  J Am Acad Dermatol       Date:  2018-11-03       Impact factor: 11.527

2.  TGF-β prevents T follicular helper cell accumulation and B cell autoreactivity.

Authors:  Mark J McCarron; Julien C Marie
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

3.  The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use?

Authors:  Asri Wijayanti; Cathy Y Zhao; David Boettiger; Yi Z Chiang; Norito Ishii; Takashi Hashimoto; Dedee F Murrell
Journal:  Acta Derm Venereol       Date:  2017-01-04       Impact factor: 4.437

4.  Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.

Authors:  T Krenacs; G Kiszner; E Stelkovics; P Balla; I Teleki; I Nemeth; E Varga; I Korom; T Barbai; V Plotar; J Timar; E Raso
Journal:  Histochem Cell Biol       Date:  2012-06-12       Impact factor: 4.304

5.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

6.  Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid.

Authors:  E Antiga; P Quaglino; W Volpi; I Pierini; E Del Bianco; B Bianchi; M Novelli; P Savoia; M G Bernengo; P Fabbri; M Caproni
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-01-18       Impact factor: 6.166

7.  M7824: A promising new strategy to combat cancer immune evasion.

Authors:  Margaret E Gatti-Mays; James L Gulley
Journal:  Oncoscience       Date:  2018-08-22

8.  Epithelial to mesenchymal transition is mediated by both TGF-β canonical and non-canonical signaling during axolotl limb regeneration.

Authors:  Fadi Sader; Jean-François Denis; Hamza Laref; Stéphane Roy
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 9.  TGFβ-Directed Therapeutics: 2020.

Authors:  Beverly A Teicher
Journal:  Pharmacol Ther       Date:  2020-08-21       Impact factor: 12.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.